1. Home
  2. CALC vs BGI Comparison

CALC vs BGI Comparison

Compare CALC & BGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CALC
  • BGI
  • Stock Information
  • Founded
  • CALC 2011
  • BGI 1879
  • Country
  • CALC United States
  • BGI Canada
  • Employees
  • CALC N/A
  • BGI N/A
  • Industry
  • CALC Biotechnology: Pharmaceutical Preparations
  • BGI
  • Sector
  • CALC Health Care
  • BGI
  • Exchange
  • CALC Nasdaq
  • BGI Nasdaq
  • Market Cap
  • CALC 36.0M
  • BGI 31.1M
  • IPO Year
  • CALC N/A
  • BGI 2005
  • Fundamental
  • Price
  • CALC $2.61
  • BGI $1.37
  • Analyst Decision
  • CALC Strong Buy
  • BGI
  • Analyst Count
  • CALC 5
  • BGI 0
  • Target Price
  • CALC $18.20
  • BGI N/A
  • AVG Volume (30 Days)
  • CALC 31.0K
  • BGI 267.3K
  • Earning Date
  • CALC 03-27-2025
  • BGI 11-27-2024
  • Dividend Yield
  • CALC N/A
  • BGI N/A
  • EPS Growth
  • CALC N/A
  • BGI N/A
  • EPS
  • CALC N/A
  • BGI N/A
  • Revenue
  • CALC N/A
  • BGI $131,596,264.00
  • Revenue This Year
  • CALC N/A
  • BGI N/A
  • Revenue Next Year
  • CALC N/A
  • BGI N/A
  • P/E Ratio
  • CALC N/A
  • BGI N/A
  • Revenue Growth
  • CALC N/A
  • BGI 4.01
  • 52 Week Low
  • CALC $2.05
  • BGI $1.32
  • 52 Week High
  • CALC $6.27
  • BGI $4.00
  • Technical
  • Relative Strength Index (RSI)
  • CALC 43.94
  • BGI 37.72
  • Support Level
  • CALC $2.32
  • BGI $1.32
  • Resistance Level
  • CALC $3.05
  • BGI $1.85
  • Average True Range (ATR)
  • CALC 0.27
  • BGI 0.19
  • MACD
  • CALC -0.01
  • BGI -0.02
  • Stochastic Oscillator
  • CALC 43.29
  • BGI 6.34

About CALC CalciMedica Inc.

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need. Its proprietary technology targets the inhibition of calcium release-activated calcium channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases for which there are no approved therapies.

About BGI Birks Group Inc.

Birks Group Inc is a part of the leisure industry. The company designs, develops, produces, and retails fine jewelry, timepieces, and gifts. Its operating segments include Retail and Other. The company generates maximum revenue from the Retail segment. Its retail segment consists of retail operations whereby it operates stores in Canada under the Maison Birks, Brinkhaus, Graff, and Patek Phillippe brands. The other segment consists mainly of wholesale business, e-commerce business, and gold exchange business.

Share on Social Networks: